CARLSBAD, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today…
— If approved in the European Union, fruquintinib will be the first novel targeted therapy for metastatic colorectal cancer regardless…
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, April 26, 2024…
Not for distribution to United States news wire services or for dissemination in the United States TORONTO and HOUSTON, April 26, 2024…
Press release, Helsinki, 26 April 2024 at 3 PM (EEST) Neurosurgery Customer from Germany Orders Nexstim NBS System 5 Nexstim…
White Paper Details Recent Trends and Provides Current Industry Data and Analysis on the Growing Nutraceutical IndustryMIAMI, April 26, 2024…
SAN DIEGO, April 26, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform…
Company to host virtual investor event on Friday, May 3, 2024, at 4:30pm EDT following presentation of results from the…
This positive CHMP opinion establishes amivantamab as a new option, and the first fully-human EGFR-MET bispecific antibody, in the first-line…
Decision by EMA follows recent judgment by the Court of Justice of the European Union regarding the organization of EMA’s…